FDA Warns CanaRx Over Drug Distribution ‘Scheme’

Drug Industry Daily
A A
The FDA hit Canadian drug distributor CanaRx with a warning letter, citing the company for supplying unapproved versions of FDA-cleared drugs.

To View This Article:

Login

Subscribe To Drug Industry Daily